As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.

Washington

District of Columbia

United States

Massive study looks at benefits, risks of GLP-1 weight-loss drugs

A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — and even some new potential upsides.

Ad Fontes Media

All Sides

Media Bias/Fact Check

New York Post

Murdoch family

New York

Massive new study finds drugs like Ozempic affect 175 conditions — including a few surprises

Ozempic, Wegovy and Mounjaro can reduce risk of heart disease, dementia, and much more, says groundbreaking US study

The Telegraph

Press Holdings

David and Frederick Barclay

London

Greater London

England

United Kingdom

Revealed: 42 health conditions weight-loss jabs can improve… and 19 they make worse

News World Communications

Health data from hundreds of thousands of Americans shows that Ozempic and co. may have a range of ‘unintended’ benefits, including a reduced risk of Alzheimer’s. But serious side effects cannot be ruled out.

Uit de gezondheidsdata van honderdduizenden Amerikanen blijkt dat Ozempic en co. een rist ‘onbedoelde’ voordelen zouden hebben, tot een verminderd risico op alzheimer toe. Maar ernstige bijwerkingen zijn niet uitgesloten.

Ozempic is zoveel meer dan diabetes- en afslankmiddel: mogelijk minder risico op verslavingen en alzheimer

Het Nieuwsblad

Mediahuis

Belgium

Ozempic is so much more than a diabetes and weight loss drug: potentially lower risk of addiction and Alzheimer's

Gazet van Antwerpen

GLP-1s – weight-loss drugs like Ozempic, Wegovy, Zepbound and Mounjaro – also may help treat a litany of other health conditions. New research shows they may help reduce the risk of addiction, Alzheimer's disease, dementia, heart disease, psychotic disorders, seizures, and suicide ideation, among other health issues.

Philly Voice

Philadelphia

Philadelphia County

Pennsylvania

Ozempic and Wegovy are helping many Americans lose weight, but they also may have other beneficial uses

HealthDay

Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes

They have been spoken of as miracle medicines: in the face of the abundant remedies and supplements that do not fulfill what they promise, GLP-1 analogues or agonists really serve to lose weight. The dream come true of effortlessly losing weight has turned the Ozempic and other brands of these drugs into products so coveted that in pharmacies they have gone missing for their original use, treating type 2 diabetes.According to a recent survey in …

Se ha hablado de ellos como medicamentos milagro: frente a los abundantes remedios y suplementos que no cumplen lo que prometen, los análogos o agonistas de GLP-1 realmente sirven para adelgazar. El sueño hecho realidad de perder peso sin esfuerzo ha convertido el Ozempic y otras marcas de estos fármacos en productos tan codiciados que en las farmacias han llegado a faltar para su uso original, tratar la diabetes de tipo 2.Según una reciente enc…

Ozempic más allá de perder peso: eleva el riesgo de padecer enfermedades de estómago, riñón o páncreas

infoLibre.es

Ozempic Beyond Weight Loss: Raises the Risk of Stomach, Kidney, or Pancreatic Disease

Once we crossed the Rubicon to use diabetes drugs like Wegovy, Ozempic, and Mounjaro for weight loss, it seemed inevitable that scientists would investigate what else these apparent wonder drugs might tackle. Now, the first study to look at how the medications affect overall health is done, and it's an...

Newser

Patrick Spain, Michael Wolff

Miami

Miami-Dade County

Florida

Ozempic, Wegovy Have 'Eye-Opening' Effects on Health

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.

Women's Health

Taking This Weight-Loss Medication Could Slash Dementia Risk, New Research Suggests

Massive study looks at benefits, risks of GLP-1 weight-loss drugs

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics